The global aerosol delivery devices market size was US$ 14.5 billion in 2021. The global aerosol delivery devices market is forecast to grow to US$ 21.1 billion by 2030 by growing at a compound annual growth rate (CAGR) of 5.1% during the forecast period from 2022 to 2030.
Request To Download Free Sample of This Strategic Report @https://reportocean.com/industry-verticals/sample-request?report_id=Pol681
Aerosol delivery devices are hand-held, portable drug distribution devices. It is a natural treatment method to treat respiratory diseases like asthma, cystic fibrosis, and COPD. The device is used to deliver insulin, analgesic medications, etc. There are various drugs available for aerosol drug delivery, such as dry powder, solution, and suspension. Moreover, aerosol delivery devices are categorized into dry powder inhalers, nebulizers, and metered-dose inhalers.
Factors Influencing the Market
The growing prevalence of COPD, asthma, and other respiratory disorders will drive the aerosol delivery devices market. For instance, a study by WHO (World Health Organization) indicates that nearly 339 million people were affected by asthma globally in the year 208. The numbers are expected to increase in the coming years.
Growing pollution and rising inclination towards smoking habits will surge the growth of the aerosol delivery devices market.
The benefits of the aerosol delivery devices, such as ease of administration, will contribute to the market growth. Furthermore, increasing demand for metered-dose inhalers and growing technological developments in the industry will benefit the market. Teva Pharmaceutical Industries Ltd. unveiled QVAR RediHaler (beclomethasone dipropionate HFA) inhalation aerosol for patients in 2018. QVAR RediHaler is a breath-actuated aerosol inhaled corticosteroid, which is highly recommended as prophylactic therapy for the treatment of asthma.
Increasing geriatric population will offer ample growth opportunities for the aerosol delivery devices market. On the contrary, the high cost associated with the treatment of asthma and COPD may limit the growth of the market.
Increasing awareness about effective inhalation therapy and growing demand for the pulmonary route of drug delivery will benefit the market. In addition, growing incidences of preterm births and lifestyle changes will escalate the market growth.
COVID-19 Impact Analysis
The sudden onset of the COVID-19 pandemic has created various difficulties for patients suffering from chronic diseases. Asthma patients also witnessed significant problems as they had to reduce visits to the hospitals. However, the demand for aerosol delivery devices increased in order to cater to the demand of the public. In addition, asthma patients were at high risk as COVID-19 can be highly dangerous for these patients. Thus, it became necessary for the patients to choose efficient devices. As a result, it surged the growth of the global aerosol delivery devices market.
Regional Analysis
This Asia-Pacific aerosol delivery devices market is forecast to grow at the highest growth rate. It is due to the growing geriatric population and the rising number of smokers. According to a research report by Japan Tobbaco Inc., the average smoking rate between the men and women of Japan was 17.9% in 2018. Furthermore, the rising prevalence of asthma and COPD will surge the growth of the regional market. For instance, according to a study by Global Asthma Report 2018, nearly 6% of children and 2% of adults suffered from asthma in 2018 in India. Thus, all these factors will contribute to the growth of the global aerosol delivery devices during the study period.
Get a Free Sample PDF copy of the report @https://reportocean.com/industry-verticals/sample-request?report_id=Pol681
Competitors in the Market
3M Company
Aerogen, INC
GlaxoSmithKline Plc (GSK)
Merck & co., INC.
Metall Zug Group (Clement Clarke International Ltd)
Koninklijke Philips N.V.
Recipharm AB (Bespak)
Johnson & Johnson (Actelion Pharmaceuticals Ltd)
Teva Pharmaceutical Industries Limited
Vectura Group PLC
Heitkamp & Thumann KG (H&T Presspart)
Iconovo AB
Gerresheimer AG
Merxin LTD
Nemera
Other Prominent Players
The report furnishes an intricate comprehension of each segment, delivering potential estimations for principal applications and insights into emerging prospects. Every regional market is meticulously scrutinized to ascertain its potential for growth, development, and demand in the forthcoming years.
As of the end of 2022, the Aerosol Delivery Devices industry experienced notable growth in its workforce. Starting in January, employment within the Aerosol Delivery Devices sector exceeded its pre-COVID levels, resulting in an expansion of payrolls by over 15,000 employees throughout the course of the year. The global Aerosol Delivery Devices output demonstrated a remarkable increase of 5.2% during 2021, primarily attributed to a widespread economic upswing and a surge in demand for commodities. However, the momentum shifted in 2022, with the global industrial sector’s production contracting. This reversal followed a robust expansion in 2021, fueled by altered consumer spending patterns and substantial fiscal support.
Forecasts indicate that the global Aerosol Delivery Devices output is set to rise by approximately 2.9% in 2023. This projection is underpinned by the gradual recovery of production in Western Europe from its previous troughs, as well as a rebound in output across the Asia/Pacific region. Maintaining its dominant position, China, accounting for nearly 45% of the global Aerosol Delivery Devices market, remains both its largest producer and consumer. Remarkably, China’s market share has surged since 2010, when it stood at around 26%. This ascent has led to a substantial contribution to the nation’s GDP. Notably excelling as a top exporter, China leads in various sectors, including silicon, PVC, and several specific segments of the Aerosol Delivery Devices market.
Market Segmentation
The global aerosol delivery devices market segmentation focuses on Product, Distribution Channel, Application, and Region.
By Product Outlook
Dry powder inhalers
Single-dose inhalers
Multi-dose inhalers
Metered-dose inhalers
Conventional pressurized inhalers,
Soft mist inhalers
Nebulizers
Jet nebulizers
Ultrasonic wave nebulizers
Vibrating mesh nebulizers
Download Sample Report, SPECIAL OFFER (Avail an Up-to 30% discount on this report ) @https://reportocean.com/industry-verticals/sample-request?report_id=Pol681
By Distribution Channel Outlook
Retail pharmacies
Hospital pharmacies
E-commerce
By Application Outlook
Asthma
Chronic obstructive pulmonary disease
Cystic fibrosis
Non-respiratory diseases
Diabetes
Analgesia
Parkinson’s disease
By Region
North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below:-https://reportocean.com/industry-verticals/sample-request?report_id=Pol681
Reasons to Acquire This Report
(A) This research imparts invaluable insights tailored for senior management, policymakers, industry professionals, product innovators, sales executives, and stakeholders within the market. It equips them with the information needed to make well-informed decisions and craft effective strategies.
(B) The report delivers a comprehensive analysis of global, regional, and country-level Aerosol Delivery Devices market revenues, extending projections until 2030. This dataset empowers companies to gauge their market presence, recognize avenues for growth, and explore emerging markets.
(C) Through meticulous segmentation of the Aerosol Delivery Devices market encompassing types, applications, technologies, and end-uses, this study empowers leaders to blueprint their products and allocate resources based on the projected growth trajectories of each segment.
(D) Investors stand to gain from the market analysis by gaining insights into market scope, positioning, key drivers, challenges, limitations, expansion prospects, and potential risks. Armed with this knowledge, they can make well-considered investment choices.
(E) The report conducts an intricate analysis of competitors, unraveling their pivotal strategies and market positioning. This intelligence equips businesses with a profound understanding of the competitive landscape, enabling them to chart their own strategies accordingly.
(F) The study facilitates the assessment of Aerosol Delivery Devices business projections delineated by region, key countries, and prominent companies, bestowing invaluable information for investment strategizing and decision-making.
Why is our study consequential?
Our study holds paramount importance for various reasons, a few of which include:
* Assisting businesses in gauging the viability of new or existing products or services.
* Facilitating business enterprises in the identification and cultivation of novel market segments.
* Providing a preemptive understanding of consumer demand prior to introducing new products, services, or features.
* Enhancing the overall efficacy of marketing, advertising, and promotional initiatives.
* Analyzing market trends to aid businesses in devising adaptive strategies.
* Guiding businesses in the optimal placement of their products.
Access Full Report Description, TOC, Table of Figure, Chart, etc.-https://reportocean.com/industry-verticals/sample-request?report_id=Pol681
About Report Ocean:
We are the best market research reports provider in the industry. Report Ocean is the world’s leading research company, known for its informative research reports. We are committed to providing our clients with both quantitative and qualitative research results. As a part of our global network and comprehensive industry coverage, we offer in-depth knowledge, allowing informed and strategic business conclusions to report. We utilize the most recent technology and analysis tools along with our own unique research models and years of expertise, which assist us to create necessary details and facts that exceed expectations.
Get in Touch with Us:
Report Ocean:
Email: [email protected]
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES
Tel:+1 888 212 3539 (US – TOLL FREE)
Website: https://reportocean.com
